ReviewCureus2025

Challenges and Opportunities of Early Parkinson's Disease Biomarkers: α-Synuclein, Leucine-Rich Repeat Kinase 2 (LRRK2), DJ-1, and microRNAs.

Allie Heineman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.